Elevance Health (ELV) Shares Outstanding (Weighted Average) (2009 - 2026)

Elevance Health (ELV) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $219.8 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $219.8 million, down 2.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $219.8 million (down 2.92% YoY), and the FY2025 annual result was $224.0 million, down 3.32% from the prior year.
• Shares Outstanding (Weighted Average) declined to $219.8 million in Q1 2026 per ELV's latest filing, from $224.0 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $241.4 million in Q1 2022 and troughed at $219.8 million in Q1 2026.
• A 5-year average of $232.9 million and a median of $232.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) fell 1.47% in 2022, then slipped 3.32% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $240.0 million in 2022, then slipped by 1.71% to $235.9 million in 2023, then decreased by 1.78% to $231.7 million in 2024, then dropped by 3.32% to $224.0 million in 2025, then dropped by 1.88% to $219.8 million in 2026.
• Business Quant data shows ELV's Shares Outstanding (Weighted Average) at $219.8 million in Q1 2026, $224.0 million in Q4 2025, and $225.0 million in Q3 2025.